Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome - PubMed (original) (raw)

Review

Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome

Gisele Zandman-Goddard et al. Semin Arthritis Rheum. 2007 Apr.

Abstract

Objective: We sought (1) to identify and (2) to define the association of all reported antibodies (Abs) with neuropsychiatric lupus (NPSLE), (3) to search for possible mechanisms that are involved in NPSLE, and (4) to determine whether we can recognize a panel of Abs associated with specific neuropsychiatric (NP) manifestations.

Methods: A MEDLINE search (1975 to 2005) was performed utilizing the following terms: neuropsychiatric lupus, antiphospholipid syndrome, or central nervous system systemic lupus erythematosus matched with the term antibodies.

Results: Twenty Abs (11 brain-specific and 9 systemic) were described in NPSLE patients. These include Abs that target brain-specific antigens (neuronal, ganglioside, synaptosomes, glia, methyl-d-aspartate receptors, lymphocytotoxic) and systemic antigens (nuclear, cytoplasmic, phospholipid, endothelial cells). Cognitive impairment, psychosis, and depression were associated with many Abs. Elevated titers of anticardiolipin Abs (aCL) were reported most often and found in patients with cognitive impairment, psychosis, depression, seizures, chorea, and migraine. No specificity was encountered among brain-specific or systemic Abs for any single NP manifestation. No studies evaluated a specific NP manifestation with the full panel of 20 Abs. A panel of brain-specific and systemic Abs may be helpful in establishing the diagnosis of NPSLE. Postulated mechanisms in experimental models included vascular occlusion and injury by pathogenic Abs in a disrupted blood brain barrier.

Conclusions: NPSLE is associated with brain-specific and systemic Abs. Cognitive impairment, psychosis, and depression were associated with many Abs, including aCL Abs. Possible mechanisms include vascular occlusion and injury by pathogenic Abs in a disrupted blood brain barrier.

PubMed Disclaimer

Cited by

Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus.
Cocco C, Manca E, Corda G, Angioni MM, Noli B, Congia M, Loy F, Isola M, Chessa E, Floris A, Lorefice L, Saba L, Mathieu A, Ferri GL, Cauli A, Piga M. Cocco C, et al. Front Immunol. 2023 Jun 13;14:1157149. doi: 10.3389/fimmu.2023.1157149. eCollection 2023. Front Immunol. 2023. PMID: 37383228 Free PMC article.
Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.
Bhangle SD, Kramer N, Rosenstein ED. Bhangle SD, et al. Rheumatol Int. 2013 Aug;33(8):1923-32. doi: 10.1007/s00296-013-2750-z. Epub 2013 Apr 16. Rheumatol Int. 2013. PMID: 23588411 Review.
Neuropsychiatric lupus and association with cerebrospinal fluid immunoglobulins: a pilot study.
Stojanovich L, Smiljanich-Miljkovich D, Omdal R, Sakic B. Stojanovich L, et al. Isr Med Assoc J. 2009 Jun;11(6):359-62. Isr Med Assoc J. 2009. PMID: 19697587 Free PMC article.
Movement disorders in paraneoplastic and autoimmune disease.
Panzer J, Dalmau J. Panzer J, et al. Curr Opin Neurol. 2011 Aug;24(4):346-53. doi: 10.1097/WCO.0b013e328347b307. Curr Opin Neurol. 2011. PMID: 21577108 Free PMC article. Review.
Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.
Sciascia S, Bertolaccini ML, Roccatello D, Khamashta MA, Sanna G. Sciascia S, et al. J Neurol. 2014 Sep;261(9):1706-14. doi: 10.1007/s00415-014-7406-8. Epub 2014 Jun 21. J Neurol. 2014. PMID: 24952022 Review.

Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome - PubMed (original) (raw)